Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'btk inhibitor 1 hydrochloride'

Search results for: 'btk inhibitor 1 hydrochloride'

Items 41-49 of 49

Page
per page
  1. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  2. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  3. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  4. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP-competitive FAK inhibitor, reversible
      ≥25.35 mg/mL
  5. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  6. Rottlerin
    B6803 Rottlerin
     1 Citation
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥23.6 mg/mL
  7. Tranexamic Acid
    B1858 Tranexamic Acid
    Target: fibrinolysis
    Summary: competitive inhibitor of plasminogen activation
      insoluble in EtOH; insoluble in DMSO; ≥6.6 mg/mL
  8. Talabostat mesylate
    B3941 Talabostat mesylate
     2 Citation
    Target: DPP-4
    Summary: orally active, specific inhibitor of DPP4
      ≥11.45 mg/mL
  9. Entrectinib
    B5859 Entrectinib
    Target: Trk Receptors|ALK|ROS1
    Summary: Orally active inhibitor of ALK kinase
      ≥28.05 mg/mL

Items 41-49 of 49

Page
per page